Shubham Pant, Michel Pierre Ducreux, Masafumi Ikeda, Xianjun Yu, Eileen M. O'Reilly, Gilda Trandafirescu, Nishanth Viswanath, Antonella Mazzei, Teresa Macarulla. "A phase 2/3 randomized study of BMS-986504 with nab-paclitaxel (nab-P) and gemcitabine (GEM) in first-line (1L) metastatic pancreatic ductal adenocarcinoma (PDAC) with homozygous
MTAP
deletion (
MTAP
-del): MountainTAP-30.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.tps796